Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.

Kwon YC, Kang JI, Hwang SB, Ahn BY.

FEBS Lett. 2013 Jan 16;587(2):156-64. doi: 10.1016/j.febslet.2012.11.010. Epub 2012 Nov 26.

2.

Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.

Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, Silverman RH, Weiss SR.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2241-6. doi: 10.1073/pnas.1519657113. Epub 2016 Feb 8.

3.

Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.

Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, Lin YL.

J Immunol. 2009 Dec 15;183(12):8035-43. doi: 10.4049/jimmunol.0902728.

4.

Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Thomas RM, Ho W.

Innate Immun. 2014 Jan;20(1):3-11. doi: 10.1177/1753425913478991. Epub 2013 Mar 25.

5.

Inhibition of the OAS/RNase L pathway by viruses.

Drappier M, Michiels T.

Curr Opin Virol. 2015 Dec;15:19-26. doi: 10.1016/j.coviro.2015.07.002. Epub 2015 Jul 29. Review.

PMID:
26231767
7.

Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus.

Zhao L, Birdwell LD, Wu A, Elliott R, Rose KM, Phillips JM, Li Y, Grinspan J, Silverman RH, Weiss SR.

J Virol. 2013 Aug;87(15):8408-18. doi: 10.1128/JVI.00769-13. Epub 2013 May 22.

8.

Porcine 2', 5'-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro.

Zheng S, Zhu D, Lian X, Liu W, Cao R, Chen P.

J Med Virol. 2016 May;88(5):760-8. doi: 10.1002/jmv.24397. Epub 2015 Oct 12.

PMID:
26437676
9.

Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.

Birdwell LD, Zalinger ZB, Li Y, Wright PW, Elliott R, Rose KM, Silverman RH, Weiss SR.

J Virol. 2016 Jan 6;90(6):3160-72. doi: 10.1128/JVI.03036-15.

10.

The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.

Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R.

J Interferon Cytokine Res. 2011 Jan;31(1):41-7. doi: 10.1089/jir.2010.0107. Epub 2010 Dec 12. Review.

PMID:
21142819
11.

Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.

Sánchez-Tacuba L, Rojas M, Arias CF, López S.

J Virol. 2015 Dec;89(23):12145-53. doi: 10.1128/JVI.01874-15. Epub 2015 Sep 23.

12.

Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein.

Naganuma A, Nozaki A, Tanaka T, Sugiyama K, Takagi H, Mori M, Shimotohno K, Kato N.

J Virol. 2000 Sep;74(18):8744-50.

13.

2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro.

Ishibashi M, Wakita T, Esumi M.

Biochem Biophys Res Commun. 2010 Feb 12;392(3):397-402. doi: 10.1016/j.bbrc.2010.01.034. Epub 2010 Jan 13.

PMID:
20074559
14.

New insights into the role of RNase L in innate immunity.

Chakrabarti A, Jha BK, Silverman RH.

J Interferon Cytokine Res. 2011 Jan;31(1):49-57. doi: 10.1089/jir.2010.0120. Epub 2010 Dec 29. Review.

15.

The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.

Ibsen MS, Gad HH, Thavachelvam K, Boesen T, Desprès P, Hartmann R.

J Virol. 2014 Dec;88(24):14222-31. doi: 10.1128/JVI.01763-14. Epub 2014 Oct 1.

16.

Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.

Mihm U, Ackermann O, Welsch C, Herrmann E, Hofmann WP, Grigorian N, Welker MW, Lengauer T, Zeuzem S, Sarrazin C.

J Hepatol. 2009 Jan;50(1):49-58. doi: 10.1016/j.jhep.2008.08.024. Epub 2008 Nov 11.

PMID:
19022516
17.

Rapid Uptake and Inhibition of Viral Propagation by Extracellular OAS1.

Thavachelvam K, Gad HH, Ibsen MS, Desprès P, Hokland M, Hartmann R, Kristiansen H.

J Interferon Cytokine Res. 2015 May;35(5):359-66. doi: 10.1089/jir.2014.0140. Epub 2014 Dec 17.

PMID:
25517543
18.

Lack of 2',5'-oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2.

Tnani M, Bayard BA.

Biochim Biophys Acta. 1998 Mar 27;1402(2):139-50.

19.

Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology.

Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR.

Cell Host Microbe. 2012 Jun 14;11(6):607-16. doi: 10.1016/j.chom.2012.04.011.

20.

Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.

Kristiansen H, Scherer CA, McVean M, Iadonato SP, Vends S, Thavachelvam K, Steffensen TB, Horan KA, Kuri T, Weber F, Paludan SR, Hartmann R.

J Virol. 2010 Nov;84(22):11898-904. doi: 10.1128/JVI.01003-10. Epub 2010 Sep 15.

Supplemental Content

Support Center